Cliff Asness’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.3M Buy
696,084
+550,807
+379% +$36.2M 0.02% 858
2026
Q1
$10.1M Sell
145,277
-334,813
-70% -$26.4M ﹤0.01% 1333
2025
Q4
$39.4M Sell
480,090
-384,642
-44% -$30M 0.02% 736
2025
Q3
$63.8M Buy
864,732
+707,810
+451% +$52.8M 0.04% 534
2025
Q2
$11.6M Sell
156,922
-55,506
-26% -$3.86M 0.01% 921
2025
Q1
$17M Sell
212,428
-24,894
-10% -$2.14M 0.02% 745
2024
Q4
$18.6M Buy
237,322
+28,445
+14% +$2.42M 0.02% 667
2024
Q3
$19.4M Sell
208,877
-66,875
-24% -$5.61M 0.03% 629
2024
Q2
$21.5M Buy
275,752
+10,111
+4% +$825K 0.03% 552
2024
Q1
$24.1M Sell
265,641
-156,868
-37% -$13.1M 0.04% 466
2023
Q4
$32.7M Sell
422,509
-138,038
-25% -$9.67M 0.06% 370
2023
Q3
$38.1M Buy
560,547
+161,373
+40% +$11.7M 0.08% 303
2023
Q2
$32M Buy
399,174
+98,682
+33% +$7.87M 0.07% 330
2023
Q1
$24.6M Buy
+300,492
New +$21.5M 0.05% 408

Other funds holding GEHC

Cliff Asness's GEHC Position: Q2 2026 in Review

Cliff Asness increased its GE HealthCare (GEHC) stake by 379% in Q2 2026, buying an estimated $36.2M and bringing the position to 696,084 shares worth $44.3M. The position accounts for 0.02% of the portfolio, ranked #858.

Cliff Asness first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $63.8M in Q3 2025. 1,221 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cliff Asness held 696,084 shares of GE HealthCare worth $44.3M as of Q2 2026.
  • Cliff Asness bought 550,807 GE HealthCare shares in Q2 2026, an estimated $36.2M.
  • GE HealthCare made up 0.02% of Cliff Asness's portfolio in Q2 2026, its #858 holding.
  • Cliff Asness first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Cliff Asness's GE HealthCare position peaked at $63.8M in Q3 2025.
  • 1,221 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.